Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

The BOOST® Nutritional Drink brand unveiled today its new BOOST® Advanced Nutritional Shake designed to support nutritional ...

Workforce resilience and risk management go hand in hand, says Aon’s Lisa Stevens. And both are critical amid the changes HR ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs , a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

With rates of obesity and anxiety both on the rise-especially among younger Americans-new research suggests that the two ...

Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, ...